European Journal of Molecular & Clinical Medicine

Abstract

There are several reports that many co morbidities can both accelerate TB disease and complicate TB treatment. It is therefore important to identify these co morbidities in people diagnosed with TB in order to ensure early diagnosis and improve co-management. When these conditions are highly prevalent in the general populations they can be important contributors to the TB burden. The research students attended ward rounds on a daily basis and collected the cases which are mentioned under the inclusion criteria. All the required parameters were analyzed thoroughly and data was pooled and analyzed. Identified adverse drug reactions and drug interactions were reported to the consultant physician on time and on daily basis. Among 250 patients, majority 182(72.8%) of the patients were found to be without any comorbidities & 68(27.2%) were with co morbidities. Patients with co morbidities were 68, out of which male patients 62(91.2%) were more in number compared to female patients 6(8.82%). There were 55 (80.88%) DM patients followed by COPD-7 (10.29%) and HIV-6 (8.83%).